Meda Pumps Up Iron With Feosol Relaunch, Revamps Neglected OTCs
This article was originally published in The Tan Sheet
Executive Summary
Meda Consumer Healthcare is relaunching the Feosol iron supplement brand with three SKUs and aims to become the clear No. 1 brand in the category. Meda’s Swedish parent company prioritizes OTC growth through brand acquisitions and increased marketing resources.
You may also be interested in...
Mylan Turns To Meda In Sweden For Open Door Into Consumer Market
The deal is subject to 90% of Meda shareholders tendering shares, and the two largest shareholders, accounting for about 30% of shares, already committed to the deal. Mylan will pay around $8.5bn in cash and debt and about $1.4bn in stock.
Mylan Turns To Meda In Sweden For Open Door Into Consumer Market
The deal is subject to 90% of Meda shareholders tendering shares, and the two largest shareholders, accounting for about 30% of shares, already committed to the deal. Mylan will pay around $8.5bn in cash and debt and about $1.4bn in stock.
Meda Keeps Traditional Geritol Formula, Tweaks Brand In Re-launch
Meda Consumer Healthcare conducted extensive consumer research on Geritol after acquiring the vitamin supplement brand from GlaxoSmithKline in 2010. Its renamed Geritol Multivitamin SKU retains the original ingredient formulation and appeals to consumers seeking simplicity in the multivitamin space.